Jonathan R. Fromm
Impact in
- Cell Biology top 0.5%
- Proteoglycans and glycosaminoglycans research
- Hematology top 2%
Papers in
-
- Lymphoma Diagnosis and Treatment 63
- Oncology 45
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 15
- Co-authors
- Robert J. Linhardt (13 shared papers)Ronald E. Hileman (9 shared papers)John M. Weiler (7 shared papers)Brent L. Wood (25 shared papers)Douglas C. Rees (1 shared paper)Salem Faham (1 shared paper)Jeffrey D. Esko (1 shared paper)Rory M. Marks (1 shared paper)
- Journals
- Cytometry Part B Clinical Cytometry (17 papers)Blood (14 papers)American Journal of Clinical Pathology (12 papers)Archives of Biochemistry and Biophysics (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesSouth AfricaGermany
In The Last Decade
Jonathan R. Fromm
98 papers receiving 4.6k citations
Jonathan R. Fromm's Hit Papers
Peers
Comparison fields: 5 of 116
- Cell Biology 1.3k
- Hematology 619
- Pathology and Forensic Medicine 924
- Immunology and Allergy 245
- Genetics 417
Countries citing papers authored by Jonathan R. Fromm
This map shows the geographic impact of Jonathan R. Fromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Fromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Fromm more than expected).
Fields of papers citing papers by Jonathan R. Fromm
This network shows the impact of papers produced by Jonathan R. Fromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Fromm. The network helps show where Jonathan R. Fromm may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan R. Fromm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Hit paper breakdown → | 1997 | 841 |
| 2 | Heparin Structure and Interactions with Basic Fibroblast Growth Factor Hit paper breakdown → | 1996 | 673 |
| 3 | 1998 | 484 | |
| 4 | 1995 | 205 | |
| 5 | 2012 | 176 | |
| 6 | 1993 | 174 | |
| 7 | 1997 | 152 | |
| 8 | 1997 | 151 | |
| 9 | 2019 | 135 | |
| 10 | 2018 | 111 | |
| 11 | 1997 | 77 | |
| 12 | 2005 | 76 | |
| 13 | 2005 | 74 | |
| 14 | 2016 | 71 | |
| 15 | 2020 | 69 | |
| 16 | 2009 | 67 | |
| 17 | 2006 | 61 | |
| 18 | 2006 | 60 | |
| 19 | 1996 | 59 | |
| 20 | 2010 | 52 |
About Jonathan R. Fromm
Jonathan R. Fromm is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Genetics and Molecular Biology, having authored 103 papers that have together received 4.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (63 papers), Chronic Lymphocytic Leukemia Research (20 papers), Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (13 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Acute Lymphoblastic Leukemia research (13 papers) and Cutaneous lymphoproliferative disorders research (9 papers). The work is most often cited by research in Cell Biology (1.3k citations), Hematology (619 citations), Pathology and Forensic Medicine (924 citations), Immunology and Allergy (245 citations) and Genetics (417 citations). Jonathan R. Fromm has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Robert J. Linhardt, Ronald E. Hileman, John M. Weiler, Brent L. Wood, Douglas C. Rees, Salem Faham, Jeffrey D. Esko, Rory M. Marks, Yaping Chen and Terry Maguire. Their work appears in journals such as Cytometry Part B Clinical Cytometry, Blood, American Journal of Clinical Pathology, Archives of Biochemistry and Biophysics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.